E-LIB Suche - Ergebnisse für: Bergmann, Kirsten R.

1

Item response theory in early phase clinical trials: Utiliz..:

Otto, Marije E. ; Bergmann, Kirsten R. ; de Kam, Marieke L....
CPT: Pharmacometrics & Systems Pharmacology. 12 (2023) 10 - p. 1425-1436 , 2023

Link: https://doi.org/10.1002/..

2

OX40L Inhibition Suppresses KLH‐driven Immune Responses in ..:

Saghari, Mahdi ; Gal, Pim ; Gilbert, Sally...
Clinical Pharmacology & Therapeutics. 111 (2022) 5 - p. 1121-1132 , 2022

Link: https://doi.org/10.1002/..

3

Population pharmacokinetics of clonazepam in saliva and pla..:

Kruizinga, Matthijs D. ; Zuiker, Rob G. J. A. ; Bergmann, Kirsten R....
British Journal of Clinical Pharmacology. 88 (2021) 5 - p. 2236-2245 , 2021

Link: https://doi.org/10.1111/..

4

A novel sustained‐release cysteamine bitartrate formulation..:

Berends, Cécile L. ; Pagan, Lisa ; van Esdonk, Michiel J....
Pharmacology Research & Perspectives. 9 (2021) 2 - p. , 2021

Link: https://doi.org/10.1002/..

5

Safety, pharmacokinetics, and pharmacodynamics of Gln‐1062,..:

Bakker, Charlotte ; van der Aart, Jasper ; Hart, Ellen P....
Alzheimer's & Dementia: Translational Research & Clinical Interventions. 6 (2020) 1 - p. , 2020

Link: https://doi.org/10.1002/..

6

First Clinical Study with AP30663 ‐ a KCa2 Channel Inhibito..:

Gal, Pim ; Klaassen, Erica S. ; Bergmann, Kirsten R....
Clinical and Translational Science. 13 (2020) 6 - p. 1336-1344 , 2020

Link: https://doi.org/10.1111/..

7

Population pharmacokinetics and pharmacodynamics of a novel..:

Snelder, Nelleke ; Hoefman, Sven ; Garcia-Hernandez, Alberto...
Journal of Pharmacokinetics and Pharmacodynamics. 48 (2020) 1 - p. 39-53 , 2020

Link: https://doi.org/10.1007/..

8

Mechanism-based modeling of the effect of a novel inhibitor..:

Hoefman, Sven ; Snelder, Nelleke ; van Noort, Martijn...
Journal of Pharmacokinetics and Pharmacodynamics. 48 (2020) 1 - p. 21-38 , 2020

Link: https://doi.org/10.1007/..

9

Development of antibiotic resistance and up-regulation of t..:

Mandsberg, Lotte Frigaard ; Maciá, Maria D. ; Bergmann, Kirsten R....
FEMS Microbiology Letters. 324 (2011) 1 - p. 28-37 , 2011

Link: https://doi.org/10.1111/..

10

Item response theory in early phase clinical trials: Utiliz..:

Otto, Marije E ; Bergmann, Kirsten R ; de Kam, Marieke L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583236/. , 2023

Link: http://www.ncbi.nlm.nih...

11

OX40L Inhibition Suppresses KLH‐driven Immune Responses in ..:

Saghari, Mahdi ; Gal, Pim ; Gilbert, Sally...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314635/. , 2022

Link: http://www.ncbi.nlm.nih...

12

A novel sustained‐release cysteamine bitartrate formulation..:

Berends, Cécile L ; Pagan, Lisa ; van Esdonk, Michiel J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992283/. , 2021

Link: http://www.ncbi.nlm.nih...

13

Population pharmacokinetics of clonazepam in saliva and pla..:

Kruizinga, Matthijs D ; Zuiker, Rob G. J. A ; Bergmann, Kirsten R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299763/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Mechanism-based modeling of the effect of a novel inhibitor..:

Hoefman, Sven ; Snelder, Nelleke ; van Noort, Martijn...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979602/. , 2020

Link: http://www.ncbi.nlm.nih...

15

Safety, pharmacokinetics, and pharmacodynamics of Gln‐1062,..:

Bakker, Charlotte ; van der Aart, Jasper ; Hart, Ellen P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551138/. , 2020

Link: http://www.ncbi.nlm.nih...